Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Computing & Software • Medical Devices & Mechanical Engineering
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Politecnico di Milano has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 6 distinct examiners, which provides a variety of examiner perspectives on their portfolio. The cases are organized within 3 distinct art units, suggesting that while the examiners are diverse, the technical focus is concentrated in a few specific areas.
The busiest examiner, LUU, THANH X, is currently handling 1 pending office action. With an equal number of distinct examiners and 6 pending actions, no single examiner holds a majority of the workload. However, the concentration into 3 distinct art units means the company is interacting with multiple examiners within the same administrative groups, which can lead to some consistency in technical requirements.
This structure requires the company to manage several different examiner relationships while navigating the standards of the specified art units. The one-to-one ratio of actions to examiners ensures that each case receives individual attention from a different person. By focusing on the practices of the specialized art units, the company can streamline its prosecution strategy for its biotechnology and pharmaceutical innovations despite the variety of examiners involved.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LUU, THANH X | 1 | 78.2% | +10.2% |
| SATCHER, DION JOHN | 1 | 84.6% | +17.8% |
| DUNLAP, JONATHAN M | 1 | 76.2% | +17.0% |
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.6% |
| AGAHI, PUYA | 1 | 49.2% | +24.4% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
| KIM, EUNHEE | 1 | 77.4% | +12.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18012737 | COMPUTER-IMPLEMENTED METHOD FOR THE GENERATION OF A MATHEMATICAL MODEL WITH REDUCED COMPUTATIONAL COMPLEXITY | KIM, EUNHEE | 4d overdue |
| 19112001 | OPTICALLY ACCESSIBLE SYSTEM FOR STUDIES ON EMBRYONATED EGGS | LUU, THANH X | — |
| 18857089 | Method to estimate in real time the likelihood of success of thrombectomy surgery | SATCHER, DION JOHN | — |
| 18853594 | GYROSCOPE WITH ENHANCED SENSITIVITY | DUNLAP, JONATHAN M | — |
| 18150694 | DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT | HELM, CARALYNNE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18012737 | COMPUTER-IMPLEMENTED METHOD FOR THE GENERATION OF A MATHEMATICAL MODEL WITH REDUCED COMPUTATIONAL COMPLEXITY | KIM, EUNHEE | 4d overdue |
| 18265649 | INTRA ORAL RESPIROMETER | AGAHI, PUYA | 13d |
| 18556992 | GEL FOR THE REGENERATION OF MUCOSAE | HOFFMAN, SUSAN COE | 26d |
| 19112001 | OPTICALLY ACCESSIBLE SYSTEM FOR STUDIES ON EMBRYONATED EGGS | LUU, THANH X | — |
| 18857089 | Method to estimate in real time the likelihood of success of thrombectomy surgery | SATCHER, DION JOHN | — |
| 18853594 | GYROSCOPE WITH ENHANCED SENSITIVITY | DUNLAP, JONATHAN M | — |
| 18150694 | DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT | HELM, CARALYNNE E | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 3791 | 1 |
| 1615 | 1 |
| 2188 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19112001 | OPTICALLY ACCESSIBLE SYSTEM FOR STUDIES ON EMBRYONATED EGGS | LUU, THANH X | — | §102§103§112 | Non-Final OA | — | Pending | Mar 14, 2025 |
| 18857089 | Method to estimate in real time the likelihood of success of thrombectomy surgery | SATCHER, DION JOHN | — | §103§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18853594 | GYROSCOPE WITH ENHANCED SENSITIVITY | DUNLAP, JONATHAN M | — | §103§112 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18556992 | GEL FOR THE REGENERATION OF MUCOSAE | HOFFMAN, SUSAN COE | 1655 | §103 | Final Rejection | 26d | Pending | Oct 24, 2023 |
| 18265649 | INTRA ORAL RESPIROMETER | AGAHI, PUYA | 3791 | §103 | Non-Final OA | 13d | Pending | Jun 06, 2023 |
| 18150694 | DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT | HELM, CARALYNNE E | 1615 | §103§112 | Final Rejection | — | Pending | Jan 05, 2023 |
| 18012737 | COMPUTER-IMPLEMENTED METHOD FOR THE GENERATION OF A MATHEMATICAL MODEL WITH REDUCED COMPUTATIONAL COMPLEXITY | KIM, EUNHEE | 2188 | §101§102§112 | Non-Final OA | 4d overdue | Pending | Dec 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial